Meningioma: current updates on genetics, classification, and mouse modeling
View abstract on PubMed
Summary
This summary is machine-generated.Meningiomas, common brain tumors, can be aggressive. Genetic mutations, like NF2 loss, influence tumor behavior, driving research into new treatments and mouse models for better understanding.
Area Of Science
- Neuro-oncology
- Genetics
- Tumor Biology
Background
- Meningiomas are the most common primary brain tumors in adults.
- While often benign and surgically curable, a subset exhibits aggressive behavior, invasion, and recurrence.
- Histopathological classification may not fully predict tumor aggressiveness or recurrence.
Purpose Of The Study
- To review recent advances in meningioma biology and classification.
- To highlight common genetic mutations and their impact on tumor behavior.
- To discuss novel genetically engineered mouse models for studying meningiomas.
Main Methods
- Analysis of large-scale molecular data including whole exome/genome sequencing, DNA methylation sequencing, and RNA sequencing.
- Review of current literature on genetic aberrations in meningiomas.
- Examination of newly developed genetically engineered mouse models.
Main Results
- NF2 loss is the most common genetic aberration, found in both low- and high-grade meningiomas.
- NF2-wildtype meningiomas frequently harbor mutations in TRAF7, KLF4, AKT1, PI3KCA, and SMO, and are often benign.
- New genetically engineered mouse models are emerging to study specific mutations.
Conclusions
- Molecular data provides new insights into meningioma biology, risk factors, and prognostic subtypes.
- Understanding genetic aberrations is crucial for predicting and treating aggressive meningiomas.
- Genetically engineered mouse models offer promising tools for future research into meningioma pathogenesis and treatment.

